Kymera Therapeutics
KYMR
KYMR
157 hedge funds and large institutions have $2.01B invested in Kymera Therapeutics in 2024 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 59 increasing their positions, 49 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
4% less funds holding
Funds holding: 164 → 157 (-7)
17% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 30
26% less capital invested
Capital invested by funds: $2.7B → $2.01B (-$691M)
Holders
157
Holding in Top 10
7
Calls
$961K
Puts
$698K
Top Buyers
| 1 | +$14.9M | |
| 2 | +$13.8M | |
| 3 | +$13.2M | |
| 4 |
UBS AM
Chicago,
Illinois
|
+$7.57M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$7.1M |
Top Sellers
| 1 | -$22.7M | |
| 2 | -$12.3M | |
| 3 | -$10.7M | |
| 4 |
Barclays
London,
United Kingdom
|
-$8.09M |
| 5 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
-$6.29M |